UPDATE 2-US FDA cites Sanofi on breast cancer drug marketing | Reuters
Links shared publicly online about this topic.
- 2,044total visits
UPDATE 2-US FDA cites Sanofi on breast cancer drug marketing | Reuters
* FDA says journal reprint is misleading * Materials overstated Taxotere's benefits -FDA * Sanofi: materials appropriate, working with FDA (Adds company comment, paragraphs 6-7) WASHINGTON, May
View full resource at reuters.com
Tags: Cancer Medication, Breast Cancer, Breast Cancer Medication, Drug, Women's Health, FDA, Taxotere, Sanofi-Aventis
Most Recently Shared on May 14, 2009 at 2:02 pm By:
FDA cites Sanofi on breast cancer drug marketing http://twurl.nl/n7jjg0
Advertisement
